JENSCARE SCIENTIFIC CO., LTD. Financials Jenscare Scientific Co., Ltd.
Equities
9877
CNE100005KC9
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.85 HKD | +4.98% |
|
+2.11% | -78.15% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 24,354 | 1,873 | 1,873 | - |
| Enterprise Value (EV) 1 | 24,354 | 8,418 | 1,873 | 1,873 |
| P/E ratio | - | -22.7 x | -9.16 x | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 116 x | 8.76 x | 3.38 x |
| EV / Revenue | - | 116 x | 8.76 x | 3.38 x |
| EV / EBITDA | -48.3 x | -19.6 x | -7.24 x | -17.3 x |
| EV / FCF | - | -4.04 x | -4.35 x | -69.4 x |
| FCF Yield | - | -24.8% | -23% | -1.44% |
| Price to Book | - | 6.83 x | 1.95 x | 1.31 x |
| Nbr of stocks (in thousands) | 417,167 | 417,167 | 417,167 | - |
| Reference price 2 | 58.38 | 4.490 | 4.490 | 4.490 |
| Announcement Date | 3/28/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | 16.21 | 213.9 | 553.4 |
| EBITDA 1 | -504.6 | -429.8 | -258.6 | -108.2 |
| EBIT 1 | -511.4 | -439.1 | -279.9 | -209 |
| Operating Margin | - | -2,023.88% | -130.89% | -37.76% |
| Earnings before Tax (EBT) 1 | - | -379.1 | -205 | - |
| Net income 1 | - | -371.7 | -205 | - |
| Net margin | - | -2,497.74% | -95.86% | - |
| EPS 2 | - | -0.8900 | -0.4900 | - |
| Free Cash Flow 1 | - | -464 | -431 | -27 |
| FCF margin | - | -2,861.61% | -201.54% | -4.88% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Announcement Date | 3/28/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | -464 | -431 | -27 |
| ROE (net income / shareholders' equity) | -33% | -28.5% | -24.5% | -9.22% |
| ROA (Net income/ Total Assets) | - | -27% | -20% | - |
| Assets 1 | - | 1,379 | 1,025 | - |
| Book Value Per Share 2 | - | 2.960 | 2.300 | 3.420 |
| Cash Flow per Share 2 | - | -0.7600 | -0.2700 | 0.6300 |
| Capex 1 | - | 18.5 | 99.5 | 25 |
| Capex / Sales | - | 114.09% | 46.53% | 4.52% |
| Announcement Date | 3/28/23 | 3/27/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.49
CNY
Average target price
39.39
CNY
Spread / Average Target
+777.44%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -78.15% | 247M | |
| +11.76% | 127B | |
| -5.10% | 11.32B | |
| +4.02% | 9.04B | |
| +38.12% | 5.56B | |
| -23.70% | 4.72B | |
| +8.55% | 3.45B | |
| -6.44% | 2.86B | |
| -5.85% | 2.07B | |
| -11.84% | 2.04B |
- Stock Market
- Equities
- 9877 Stock
- Financials Jenscare Scientific Co., Ltd.
